Vanguard Group Inc Blueprint Medicines Corp Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Vanguard Group Inc holds 6,774,884 shares of BPMC stock, worth $559 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,774,884

Previous 6,683,434 1.37%

Holding current value

$559 Million

Previous $618 Million 4.38%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$82.48 - $101.39 $7.54 Million - $9.27 Million	91,450 Added 1.37%	6,774,884 $591 Million
Q3 2024 Nov 13, 2024	BUY	$84.1 - $120.5 $12.2 Million - $17.5 Million	144,968 Added 2.22%	6,683,434 $618 Million
Q2 2024 Aug 13, 2024	BUY	$85.18 - $108.78 $19.5 Million - $24.9 Million	228,489 Added 3.62%	6,538,466 $705 Million
Q1 2024 May 10, 2024	BUY	$73.17 - $99.79 $14.3 Million - $19.5 Million	195,007 Added 3.19%	6,309,977 $599 Million
Q4 2023 Feb 14, 2024	BUY	$43.96 - $92.84 $6.5 Million - $13.7 Million	147,827 Added 2.48%	6,114,970 $564 Million
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $1.77 Million - $2.49 Million	37,716 Added 0.64%	5,967,143 $300 Million
Q2 2023 Aug 14, 2023	BUY	$42.2 - $66.37 $2.13 Million - $3.35 Million	50,483 Added 0.86%	5,929,427 $375 Million
Q1 2023 May 15, 2023	BUY	$37.97 - $50.0 $3.97 Million - $5.22 Million	104,488 Added 1.81%	5,878,944 $264 Million
Q4 2022 Feb 10, 2023	BUY	$41.06 - $66.48 $4.65 Million - $7.54 Million	113,353 Added 2.0%	5,774,456 $253 Million
Q3 2022 Nov 14, 2022	BUY	$49.93 - $77.7 $2.21 Million - $3.44 Million	44,292 Added 0.79%	5,661,103 $373 Million
Q2 2022 Aug 12, 2022	BUY	$45.23 - $70.15 $4.15 Million - $6.44 Million	91,751 Added 1.66%	5,616,811 $284 Million
Q1 2022 May 13, 2022	SELL	$54.1 - $110.08 $471,265 - $958,906	-8,711 Reduced 0.16%	5,525,060 $353 Million
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $4.65 Million - $5.73 Million	-49,361 Reduced 0.88%	5,533,771 $593 Million
Q3 2021 Nov 12, 2021	BUY	$80.98 - $109.47 $1.42 Million - $1.93 Million	17,589 Added 0.32%	5,583,132 $574 Million
Q2 2021 Aug 13, 2021	BUY	$82.78 - $101.0 $461 Million - $562 Million	5,565,543 New	5,565,543 $490 Million

Others Institutions Holding BPMC

# of Institutions

379

Shares Held

61.5M

Call Options Held

1.6M

Put Options Held

1.41M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $4.93B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Blueprint Medicines Corp Transaction History